It belongs to the class of medications known as oral hypoglycemics. Our immense market knowledge and expertise have helped us in emerging as a trusted organization engaged in offering Gliclazide. It is used as an oral antihyperglycemic agent, for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). This drug increases both basal insulin secretion and meal-stimulated insulin release. Gliclazide increases the amount of insulin released by the pancreas and helps the body use insulin more efficiently.